GLSI Stock Analysis: Buy, Sell, or Hold?
GLSI - Greenwich LifeSciences, Inc.
$24.06
1.03 (4.47%)
▲
5d:
+8.13%
30d:
-4.9%
90d:
-10.02%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Jun 02, 2026
0d
Get Alerted When GLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: GLSI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: GLSI is currently trading at $24.06, which is considered slightly low relative to its 30-day fair value range of $23.04 to $27.50.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $20.91, while resistance sits at $29.93. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.50 (+97.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GLSI is in a downtrend. Immediate support is located at $20.91, while resistance sits at $29.93. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.50 (+97.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$23.04 -
$27.50
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 97.4% below Wall St target ($47.50)
Trading Range Analysis
30-Day Trading Range
$23.04 -
$27.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.91
Resistance Level
$29.93
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$47.50
(+97.4%)
Share & Embed Analysis
Last updated: June 15, 2026 5:07 AM ET
Data refreshes hourly during market hours. Next update: 6:07 AM
Data refreshes hourly during market hours. Next update: 6:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLSI showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Snehal Patel
BUY
1800 shares
2026-01-13
Snehal Patel
BUY
2900 shares
2026-01-12
Snehal Patel
BUY
4300 shares
2025-12-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 54 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 52 HOLD |
